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OBJECTIVE — The purpose of this study was to clarify the effects of maternal obesity on
insulin sensitivity and secretion in offspring.
RESEARCH DESIGN AND METHODS — Fifty-one offspring of both sexes of obese
(Ob group) and 15 offspring of normal-weight (control group) mothers were studied. Plasma
glucose, insulin, and C-peptide were measured during an oral glucose tolerance test (OGTT).
Insulin sensitivity was calculated using the oral glucose insulin sensitivity index, and insulin
secretion and -cell glucose sensitivity were computed by a mathematical model. Fasting leptin
and adiponectin were also measured. Body composition was assessed by dual-X-ray
absorptiometry.
RESULTS — No birth weight statistical difference was observed in the two groups. Of the Ob





0.0001; 416.42  76.17 vs. 484.242  45.76 ml
1   min
1   m
2 in men, P  0.05). Insulin
secretion after OGTT was higher in Ob group than in control group men (63.94  21.20 vs.
35.71  10.02 nmol   m
2, P  0.01) but did not differ signiﬁcantly in women. -Cell glucose
sensitivity was not statistically different between groups. A multivariate analysis of variance
showed that maternal obesity and offspring sex concurred together with BMI and -cell glucose
sensitivity to determine the differences in insulin sensitivity and secretion observed in offspring.
CONCLUSIONS — Obese mothers can give birth to normal birth weight babies who later
develop obesity and insulin resistance. The maternal genetic/epigenetic transmission shows a
clear sexual dimorphism, with male offspring having a higher value of insulin sensitivity (al-
though not statistically signiﬁcant) associated with signiﬁcantly higher insulin secretion than
female offspring.
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T
ype 2 diabetes is spreading out
among young people as the inci-
dence of obesity is increasing over
time. This evidence has induced the
American Diabetes Association (1) to in-
clude into the new classiﬁcation recom-
mendations of diabetes a form of type 2
diabetes with pubertal onset, variable in-
sulin secretion, and decreased insulin
sensitivity, strongly associated with obe-
sity, which includes 10–20% of all diabe-
tes in childhood and youth.
Scientistshaveprovidedapathophys-
iologicalexplanationofthisphenomenon
by suggesting that the development of
type 2 diabetes in youth reﬂects the com-
bination of insulin resistance and relative
insulin deﬁciency. However, the limited
-cell capacity is regarded as being of “lit-
tle signiﬁcance” (2) in the absence of
obesity.
FamilialaggregationofBMIiswelles-
tablished in the medical literature. In a
Swedish study on monozygotic twins
reared in different familial contexts, with-
in-pair correlations for BMI were 70% for
men and 66% for women; these ﬁgures
were quite similar for twins reared to-
gether, suggesting that familial environ-
mentdidnotplayarelevantroleinBMIin
identical twins (3). Similar values for cor-
relation coefﬁcients (75%) were also
found in a U.S. population of monozy-
gotic twins (4).
However, epigenetics also seems to
contribute, together with genetic predis-
position, to the development of obesity.
Studies of inheritance unequivocally
showthatBMIofchildrencorrelatesmore
closely with maternal than with paternal
BMI, suggesting that in addition to the
genetic inﬂuences, the in utero environ-
ment may contribute to the development
of obesity in offspring. In fact, over-
weight/obese women are more likely to
give birth to heavier babies (90th cen-
tile) than normal-weight mothers (5).
Studies of inheritance clearly demon-
strated a stricter correlation between a
child’s BMI and maternal rather than pa-
ternal BMI, suggesting that the in utero
environmentmaycontributetothedevel-
opment of obesity in offspring (6,7).
Gillman et al. (8) found that maternal BMI
was an inﬂuencing variable in association
with gestational diabetes and offspring
obesity. Furthermore, Khan et al. (9–11)
demonstrated that the consumption of a
diet rich in saturated fat starting before
conception and continuing through
weaning led to increased hyperinsulin-
emia, adiposity, hypertension, and endo-
thelial dysfunction in offspring at 6
months of age. Very recently, Shankar et
al. (5) demonstrated that, at least in rats,
maternal overweight at conception con-
tributes to offspring obesity and insulin
resistance and that programming of obe-
sity occurs in the absence of changes in
birth weights.
However, at least to our best knowl-
edge, there is only one study (12) in the
literature that investigated insulin sensi-
tivity but not insulin secretion in young
lean offspring of obese parents compared
with offspring of normal-weight parents.
This study (12) failed to demonstrate any
signiﬁcant difference between groups.
Our center follows obese subjects
almost exclusively, and morbidly obese
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tient population. Recently, we have
started to systematically study insulin
sensitivityandinsulinsecretionintheoff-
spring of obese and morbidly obese pa-
tients, after the observation that some of
the young individuals with at least one
parent, usually the mother, affected by
obesity had impaired glucose tolerance
(IGT) and/or hypertension independent
oftheirbodyweight.Inthepresentinves-
tigation insulin sensitivity, insulin secre-




METHODS— Our study population
consisted of 67 offspring (39 women and
28 men) with an average age of 23.8 
4.50years.Toevaluatetheassociationsof
juvenile obesity and insulin resistance
with the maternal degree of obesity, we
sought to conduct a family-based study.
Mothers were asked details of their
pregnancy and child’s birth. It was not
possible to obtain detailed information
about weight gain during pregnancy or in
early life.
Offspring of obese mothers
The Ob group consisted of 52 subjects
(31 women and 21 men) who were off-
springof22obesemothers.Maternalobe-
sity was deﬁned as a documented BMI of
30kg/m
2beforeandduringpregnancy.
One to three subjects from each family
were included. The mean  SD age of the
parents, who did not have a history of
diabetes or IGT, was 49.14  3.26 years
for the mothers and 51.64  5.11 years
forthefathers;mothers’BMIwas41.87
8.62 kg/m




The control subjects had to fulﬁll the fol-
lowing inclusion criteria: 1) age from 16
to 31 years; 2) no diabetes, IGT, or im-
paired fasting glucose (IFG); 3) no ﬁrst-
degree relatives with a history of diabetes
or obesity; 4) no drug treatment or any
disease that could potentially disturb car-
bohydrate metabolism; and 6) no history
of hypertension. The control group con-
sisted of 15 offspring (8 women and 7
men) of 6 normal-weight (BMI 25
kg/m
2) mothers, who met the inclusion
criteria. One to three subjects from each
familywereexamined.Theageofthepar-
ents, who did not have history of diabetes
or IGT, was 48.33  3.83 years for the
mothers and 50.00  3.03 years for the
fathers; mothers’ BMI was 22.69  1.68
kg/m




orally) glucose between 7.8 and 11.1
mmol/l, and diabetes was diagnosed
when 2-h postload glucose was 11.1
mmol/lorfastingglucosewas7mmol/l,




type 2 diabetes in two generations.
None of the subjects had lost weight or
changed his or her dietary habits during
the 4–6 months preceding the study,
and none was taking any medication
that could inﬂuence insulin secretion or
insulin sensitivity.
The study was approved by the insti-
tutional review board of the School of
Medicine, Catholic University, Rome, It-
aly. All of the subjects gave their written
informed consent before starting the
study.
Experimental protocol
All subjects received a 75-g oral glucose
tolerance test (OGTT). Venous blood
samples were collected at 30-min inter-
vals over 2 h for plasma glucose, insulin,
and C-peptide measurements. Fasting
blood samples were obtained after an
overnight fast (12–14 h) to measure glu-
cose, insulin, C-peptide, adiponectin,
and leptin concentrations.
Body composition was assessed by
dual-energy X-ray absorptiometry (Lunar
Prodigy GE Medical Systems, Madison,
WI), and fat-free mass and fat mass were
computed. Height was measured in cen-
timeters using a stadiometer. Weight was
measured in kilograms using an elec-
tronic scale. Waist circumference was
measured just above the uppermost lat-
eral border of the right ileum using the
National Health and Nutrition Examina-
tion Survey protocol (13). Height and
weightmeasurementswereusedtocalcu-
late BMI. Normal weight was deﬁned as
BMI 25 kg/m
2, overweight as BMI be-
tween 25.1 and 29.9 kg/m
2, obesity as
BMI between 30.1 and 40 kg/m
2, and
morbid obesity as BMI 40 kg/m
2.
Analytical procedures
Plasma was immediately separated by
centrifugationat4°Candstoredat80°C
until assay. The samples were not thawed
until hormone assays were performed.
Plasma glucose was measured by the glu-
cose oxidase method (Beckman, Fuller-
ton, CA). Plasma insulin was assayed by
microparticle enzyme immunoassay
(MEIA;Abbott,Pasadena,CA)withasen-
sitivity of 1 U/ml and an intra-assay co-
efﬁcient of variation (CV) of 6.6%.
C-peptide was assayed by radioimmuno-
assay (MYRIA; Technogenetics, Milan, It-
aly); this assay has a minimal detectable
concentration of 17 pmol/l and intra-
assay and interassay CVs of 3.3–5.7 and
4.6–5.3, respectively. Plasma adiponec-
tin levels were measured using a radioim-
munoassay (Linco, St. Charles, MO) with
a sensitivity of 1 g/ml and an intra-assay
CV of 6.2%. Plasma leptin was assayed by
radioimmunoassay for human leptin
(Phoenix Pharmaceuticals, Phoenix, AZ).
Intra- and interassay CVs were 4.2 and
4.5%, respectively. The sensitivity of the
method was 0.5 ng/ml.
Insulin sensitivity and -cell
function
Insulinsensitivitywascalculatedfromthe
OGTT according to the method of Mari et
al. (14), using the 2-h OGTT equation.
This method provides an insulin sensitiv-
ity (OGIS) index that is an estimate of the
glucose clearance during a euglycemic-
hyperglycemic clamp, expressed in milli-
litersperminutepersquaremeterofbody
surface area.
-Cell function was assessed using a
model describing the relationship be-
tween insulin secretion and glucose con-
centration, which has been illustrated in
detail previously (15–17). The character-
istic parameter of the dose response is the
mean slope within the observed glucose
range, denoted as -cell glucose sensitiv-
ity. The dose response is modulated by a
potentiation factor, which accounts for
several potentiating factors (prolonged
exposure to hyperglycemia, nonglucose
substrates, gastrointestinal hormones, in
particular gastric inhibitory polypeptide
and glucagon-like peptide-1, and neuro-
transmitters). The potentiation factor is
set to be a positive function of time and to
average 1 during the experiment. Thus, it
expresses a relative potentiation of the se-
cretory response to glucose.
The model parameters were esti-
mated from glucose and C-peptide con-
centrations by regularized least squares,
as described previously (15,16). Regular-
ization involves the choice of smoothing
factors that were selected to obtain glu-
cose and C-peptide model residuals with
SDs close to the expected measurement
Mingrone and Associates
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peptide).
Basal and total insulin secretion dur-
ing the OGTT were calculated from the
estimated model parameters. Total insu-
linsecretionwascalculatedastheintegral
over the2ho ft h eOGTT. Insulin secre-
tion was expressed in picomoles per
minute per square meter of body surface
area.
Statistical analysis
Data analyses were performed with SPSS
statistical software (SPSS, Chicago, IL).
Two-sided P  0.05 was regarded as sig-
niﬁcant.DataarereportedasmeansSD
unless otherwise speciﬁed. A nonpara-
metric Mann-Whitney U test was used to
assess differences in subjects’ variables.
Pearson’s coefﬁcients were calculated to
quantify the correlations among different
parameters. Multivariate analysis of vari-
ance was used to assess the effect of cate-
goricalvariablesoninsulinsensitivityand
secretion. The statistical method for cal-
culating the equation is reported on the
following page. The minimal level of sta-
tistical signiﬁcance was deﬁned as P 
0.05.
RESULTS— Table 1 reports demo-
graphic, body composition, and bio-
chemicaldataaswellasinsulinsensitivity
and secretion parameters. According to
their BMI, 86.67% of the control group
were normal weight and 13.33% were
overweight; whereas only 11.54% of the
Ob group were normal weight, 19.23%
were overweight, 50% were obese, and
19.23% were morbidly obese. Despite a
trend toward a higher body weight in the
offspring of the obese mothers, no signif-
icant difference in birth weight was ob-
served either in men or in women,
probably as a consequence of a rather
largedispersionofthedata(controlgroup
women 3,167  230 g; control group
men 3,301  240 g; Ob group women
3,697  605 g; and Ob group men
3,759  555 g).
In the Ob group, one woman (BMI
44.39 kg/m
2) was frankly diabetic, and 8
of 52 had IGT, with a sex ratio (male/
female) of 1:3 and an average BMI of
35.11  11.60 kg/m
2 (minimum 20.70;
maximum 51.97). Fasting glucose levels
were similar in the two groups, whereas
mean OGTT glucose was signiﬁcantly
higherintheObgroupthaninthecontrol
group (6.9  1.6 vs. 5.6  1.2 mmol/l,
P  0.01).
Ob group subjects were more insulin
resistant than control group subjects
(410  91 vs. 500  60 ml
1   min
1  
m
2, P  0.001). However, whereas men
compensatedforinsulinresistancebysig-
niﬁcantly increasing insulin secretion
both at fasting and after the OGTT, insu-
lin secretion in Ob group women was not
statistically different from that in control
group women (Table 1).
In the control group, multiple regres-
sion analysis with the OGIS index as the
dependent variable and constant, BMI, fat
mass, fat-free mass, waist circumference,
sex, basal insulin secretion, total insulin se-
cretion,adiponectin,andleptinasindepen-
dent variables (model R
2  0.47, P 
0.028)showedthatthebestpredictorofin-
sulin sensitivity was the total insulin secre-
tion after the OGTT. In contrast, in the Ob
groupthebestpredictorsofinsulinsensitiv-
ity were total insulin secretion after the glu-
cose challenge, sex, and circulating leptin
levels, as summarized in Table 2.
-Cell glucose sensitivity (picomoles
per minute per square meter per millimo-
lar) was not statistically different between
groups or between sexes (237.64 
173.39 in control group women and
123.70  32.10 in control group men;
Table 1—Demographic, body composition, biochemical and insulin sensitivity, and secretion
dataofthestudypopulation,includingmaleandfemaleoffspringofnormal-weight,obese,and
morbidly obese mothers
Control group Ob group
n (women/men) 8/7 31/21
Age (years)
Women 23.75  2.96 23.63  4.43
Men 26.00  5.74 24.41  4.83
BMI (kg/m
2)
Women 21.45  3.07 34.94  8.53*
Men 24.80  2.83 32.55  5.31†
Waist circumference (cm)
Women 69.71  2.63 104.77  17.04*
Men 83.13  5.27 106.47  10.68‡
Fat mass (kg)
Women 12.38  2.73 29.67  11.52*
Men 16.26  2.55 31.51  8.77*
Fat-free mass (kg)
Women 44.21  7.26 64.65  12.99*
Men 57.03  6.22 69.61  8.08‡
Adiponectin (g/ml)
Women 13.62  6.40 8.57  3.81§
Men 10.04  2.87 6.53  3.41§
Leptin (ng/ml)
Women 9.24  5.45 26.52  19.04‡
Men 6.16  2.79 11.51  2.88‡
Mean glucose (mmol/l)
Women 5.33  1.30 6.91  1.69‡
Men 5.98  1.17 6.82  1.35
Mean insulin (pmol/l)
Women 351.05  168.42 589.37  472.17
Men 206.71  85.59 575.07  300.45*
Fasting insulin secretion (pmol   min
1   m
2)
Women 88.70  29.76 118.80  45.91
Men 72.21  23.55 126.80  47.97§
Total insulin secretion (nmol/m
2)
Women 40.97  18.95 54.70  23.78
Men 35.71  10.02 63.94  21.20‡
OGIS (ml   min
1   m
2)
Women 513.81  70.70 398.58  79.32*
Men 484.242  45.76 416.42  76.17§
Data are means  SD. *P  0.0001; †P  0.001; ‡P  0.01; §P  0.05 compared with normal-weight
offspring.
Maternal obesity effects in offspring
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and 177.49  90.37 in Ob group men).
A multiway mixed-model ANOVA
was used to analyze the effect of maternal
obesity on insulin sensitivity and secre-
tion. The equation, reported below, had
the offspring phenotypes (insulin sensi-
tivity and secretion) as dependent vari-
ables, the main effect factors of sex (male
versus female) and maternity (born of
normal weight or of obese mother) as
ﬁxed factors, and BMI, adiponectin, and
leptin concentrations as cofactors:
Y  intercept 	 BMI 	 adiponectin
 leptin 	 -cell glucose sensitivity
 maternity 	 sex 	 maternity
 sex
Thenullhypothesis,thattheobservedco-
variance matrices of the dependent vari-
ables, i.e., insulin sensitivity and insulin
secretion, were not different between the
two groups, i.e., obese versus nonobese
mothers, was rejected by the model (F 
0.885, P  0.538).
The results of the multivariate test are
summarized in Table 3. Maternal obesity
together with sex concurred with the BMI
and -cell glucose sensitivity to deter-
mine the differences in insulin sensitivity
and secretion observed in the offspring.
No signiﬁcant correlation was found
between plasma leptin levels and insulin
secretion, whereas leptin was negatively
and signiﬁcantly correlated with insulin
sensitivity (R
2  0.314, P  0.017). In
contrast, adiponectin negatively (R
2 
0.303, P  0.022) correlated with the
basal insulin secretion and positively
(R
2  0.394, P  0.002) with the insulin
sensitivity.
CONCLUSIONS— At least to the
best of our knowledge, this is the ﬁrst re-
port in humans focusing on the effect of
maternal obesity during pregnancy on
offspringinsulinsensitivityandsecretion.
The major ﬁnding of the present study is
that obese mothers can give birth to nor-
mal-weightbabieswholaterdevelopobe-
sity.Infact,obesityduringpregnancywas
associated with a high prevalence of over-
weight and obesity (overall 88%), as
well as with insulin resistance and hyper-
insulinemia, but not with -cell glucose
sensitivity impairment, in young adult
offspring. Our study conﬁrms in humans
the data reported in rats by Shankar et al.
(5), who showed that maternal over-
weight at conception contributes to off-
spring obesity and insulin resistance in
the absence of changes in birth weights.
In this regard, it has been clearly demon-
strated in animals that conditions such as
undernutrition and high-fat feeding dur-
ing gestation can predispose offspring to
become obese (18,19).
Asshownbyamultivariateanalysisof
variance, maternal obesity together with
offspring sex concurred to determine the
differences in insulin sensitivity and se-
cretion observed in offspring, thus high-
lighting a sex dimorphism of the
epigenetic mechanism of transmission. A
higher susceptibility of the female prog-
eny to epigenetic insults has been already
recognizedinanimals(20,21).Toexplain
this sexual dimorphism, it has been hy-
pothesized that the differential suscepti-
bilitytocomplexdiseases,suchasobesity
and diabetes, in men and women is me-
diated by differences in the epigenetic
regulation of genes induced by sex hor-
mones (22).
Furthermore, although our popula-
tion sample was small, our study design
has evidenced a familial aggregation of
obesity, suggesting a genetic susceptibil-
ity to epigenetic insults during preg-
nancy. Thus, the present results might be
useful in designing a larger-scale family-
based epidemiological study.
There is a wide acceptance of the no-
tion that children born to overweight
mothers are at higher risk of becoming
overweight themselves (5–8). However,
the question of the role played by the de-
gree of overweight-obesity of the mothers
in this offspring predisposition or its ef-
fect on offspring insulin sensitivity and
secretionwasnotspeciﬁcallyaddressedin
previous studies.
Controversial results have been re-
portedinthefewavailablereportsregard-
ing insulin sensitivity and/or secretion in
children from obese probands, and the
majority of the studies were retrospective
investigations. Two-thirds of subjects
who later developed type 2 diabetes fol-
lowed a lower birth weight-postnatal
Table 2—Multiple regression analysis in offspring of obese mothers
Model B coefﬁcient SEM P value
Partial
correlations
Constant 552.05 108.88 0.0001
Sex 84.44 31.10 0.011 0.46
BMI 2.92 4.08 NS 0.14
Fat mass 2.490 2.395 NS 0.20
Fat-free mass 1.370 2.741 NS 0.10
Waist circumference 1.393 1.250 NS 0.21
Adiponectin 4.780 3.136 NS 0.28
Leptin 1.843 0.758 0.022 0.42
Basal insulin secretion 0.276 0.415 NS 0.13
Total insulin secretion 2.866 0.615 0.0001 0.67









Intercept 256.82 90.87 0.0001
BMI (kg/m
2) 20.99 7.44 0.002
Adiponectin (g/ml) 0.85 0.30 NS
Leptin (ng/ml) 2.28 0.79 NS
-Cell glucose sensitivity
(pmol   min
1   m
2 mol
1   l
1  )
19.63 6.94 0.002
Maternal obesity 4.94 1.75 NS
Sex 0.91 0.33 NS
Maternal obesity 
 sex 9.88 3.50 0.039
Mingrone and Associates
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thirdshowedlargerbirthsizefollowedby
poor growth in stature (23). In another
investigation (24), childhood-onset type
2 diabetes was associated with either low
birth weight or high birth weight. Ong et
al. (25) reported that insulin secretion
was reduced in children with low birth
weight, irrespective of whether they sub-
sequently developed overweight or insu-
lin resistance, suggesting a possible
programming of pancreatic -cell mass
and/orfunctioninutero.However,inthis
latter study, insulin sensitivity was as-
sessed using the homeostasis model and
insulin secretion was estimated by the in-
sulinogenic index. Thus, a direct measure
of insulin secretion was not obtained.
Lazarin et al. (12) have investigated
theroleofparentalinﬂuenceinthedevel-
opment of insulin resistance, not consid-
ering, however, insulin secretion
abnormalities. The authors (12) did not
ﬁnd any inﬂuence of familial obesity on
insulin sensitivity in offspring; however,
in this investigation lean offspring were
considered and the fathers were obese,
whereas mothers were only overweight.
In our series, the mothers had different
BMIs, whereas the BMI of the fathers was
similar. These different results might be
attributable to a maternal transmission,
eithergeneticorepigenetic.Inaddition,it
is interestingly to note that male offspring
ofobesemotherscompensatedforinsulin
resistance by increasing insulin secretion.
Leptin and adiponectin circulating levels
did not explain any difference in insulin
sensitivity and secretion between sexes.
In summary, obese mothers can give
birth to normal-weight babies who later
develop obesity and insulin resistance.
The maternal genetic/epigenetic trans-
missionshowsaclearsexualdimorphism,
with male offspring having higher insulin
sensitivity (although not statistically sig-
niﬁcant) associated with a signiﬁcantly
higher insulin secretion than the female
offspring. Whether these results are de-
pendent on maternal genetic transmis-
sion, for instance through mitochondrial
DNA, or epigenetic phenomena occur-
ring during fetal development, will be the
focus of further studies.
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